Jd Health International Inc (6618:HK) Annual Income Statement ()
6618:HK Quarterly Financials ()
Frequently Asked Questions About Jd Health International Inc (6618:HK) Stock
Jd Health International Inc's (6618:HK) last reported annual revenue was HKD 53.53 Billion.
Jd Health International Inc's (6618:HK) annual revenue growth rate based on the revenue reported in the past 5 years is : 45.64%
Jd Health International Inc's(6618:HK) is profitable as of its last reported annual financials.
The net profit margin for Jd Health International Inc's(6618:HK) from its laster reported year is 4.00%
The return on equity (ROE) for Jd Health International Inc's(6618:HK) from its last reported annual financials is : 5.19%
The return on assets (ROA) for Jd Health International Inc's(6618:HK) from its last reported annual financials is : 0.77%
The return on invested capital (ROIC) for Jd Health International Inc's(6618:HK) from its last reported annual financials is : 1.49%
The Debt to Equity ratio for Jd Health International Inc's(6618:HK) from its last reported annual financials is : 0.00%
The dividend yield for Jd Health International Inc's(6618:HK) from its laster reported year is 0.00%
Jd Health International Inc's(6618:HK) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 6618:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
